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Summary 
RORt is a nuclear hormone receptor that has followed an exponential success carrier. 
Its modest origins as an orphan receptor cloned from human pancreas blossomed 
within 15 years into a critical regulator of anti-microbial immunity and a major target 
in the fight against inflammatory pathologies. Here, I review its role as a transcription 
factor required for the generation of type 3 lymphoid cells, which induce the 
development of lymphoid tissues, provide resistance of epithelial stem cells to injury, 
maintain homeostasis with the symbiotic microbiota,orchestrate defense against 
extracellular microbes and regulate allergic responses. RORt is also an intriguing 
molecule that is regulated by the circadian rhythm and includes cholesterol 
metabolites as ligands. RORttherefore links anti-microbial immunity with circadian 
rhythms and steroids, the logic of which remains to be understood.  
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A brief history of RORt 
Two independent lines of research lead to the discovery ofROR and its shorter 
isoform RORt. In the first line of research, PCR primers were designed to amplify 
cDNAs coding for conserved regions of the DNA binding domain of nuclear hormone 
receptors. This strategy aimed for the cloning of presumably all nuclear receptors 
expressed in a given tissue or cell line. Using this approach, novel orphan receptors 
named retinoid Z receptor (RZR) and RZRwere then identified in umbilical vain 
endothelial cells 
1
 and rat brain
2
. In addition, using hybridization cloning with the 
cDNA of the retinoic acid receptor (RAR), retinoic acid related orphan receptor 
(ROR) was identified in rat brain and shown to be identical to RZR3. This lead to 
the identification of the third member of the RZR/ROR family, ROR, in a cDNA 
library from human pancreas,and later from mouse muscle, using the degenerate 
primer approach
4, 5
. Interestingly, melatonin was reported to activate the transcription 
factor activity of ROR and RORin cultured cells6-8, suggesting early on a role 
forthe ROR family of receptors in circadian rhythms. 
 In the second line of research, in a screen for proteins that confer resistance to 
TCR-mediated apoptosis,a shorter isoform of ROR was identified by expression 
cloning of a thymocyte cDNA library in a T cell hybridoma
9
. While ROR is 
expressed in a variety of organs, this new isoform was found to be primarily 
expressed in the thymus and was therefore named RORt. Mice that lacked the 
expression of both ROR and RORt showed increased thymocyte apoptosis9-11. Such 
mice also had theremarkable phenotype of lacking lymph nodes and Peyer’s patches. 
In knock-in mice in which the Rorc(t) locus coded for GFP instead of RORt, but 
still expressed ROR, it was shown that RORt is expressed by and is required for the 
development of fetal lymphoid tissue inducer (LTi) cells
12
, a then enigmatic cell type 
that colonizes developing lymphoid tissues in the fetus before any other 
hematopoietic cell type
13-15
.  
 It was nevertheless the association of RORt with Th17 cells that shot RORt 
to universal fame. In a landmark paper by Dan Cua and colleagues, it was 
demonstrated that IL-23, rather than IL-12,is the critical cytokine in experimental 
autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis
16
. In a 
second paper, Cua reported that IL-23 promotes the generation of Th17 cells, the 
effector cells that driveEAE
17
. On the basis of transcriptome profiles, Th17 cells were 
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found to express high levels of RORt as compared to Th1 cells, an observation that 
lead to the demonstration that Th17, like LTi cells, expressed RORt and required 
RORt for their generation18.  
 Two years later, the world of RORt+ cells expanded again. A population of 
LTi-like cells was identified that express markers of NK cells, such as NKp46, as well 
as the signature cytokines IL-17 and IL-22, but do not cluster and induce the 
development of lymphoid tissues
19-22
. To keep controlof the expanding universe of 
LTi-likecells, the term “innate lymphoid cells” (ILCs) was coined23, 24. It was 
progressively realized that the ILC universe includes ILC1s, ILC2s and (RORt+) 
ILC3s, which mirror Th1, Th2 and Th17 cells in the expression of signature 
transcription factors, surface markers and effector cytokines
25
.  
 A recent observation brings RORt back full circle to its original description 
as a cousin of the melatonin receptorsROR and ROR6-8. RORis a component of 
the transcriptional network of peripheral circadian clocks
26, 27
, which regulates the 
transcription factor Nfil3, which in turn represses the expression of RORt28. 
Deregulation of the circadian clock thus leads to a deregulation of Th17 cells and 
increased susceptibility to inflammatory pathology. Finally, and no less intriguing, 
cholesterol metabolites are natural ligands of RORt29, 30, possibly linking type 3 
immunity to the endocrine system and metabolism, even though the biology of these 
ligands remains to be understood. 
 
RORt and lymphoid tissue development 
LTi cells were first describedas CD3
-
CD4
+
or CD3
-
IL-7R+cells in the developing 
lymph nodes (LNs)
13, 14
and Peyer’s patches (PPs)15 (Figure 1). Mebius’ and 
Nishikawa’s labs characterizedLTi cells and their interactions with stroma cellswithin 
the lymphoid tissue anlagen
31, 32
, but it is the discovery of RORt that allowed to 
demonstrate formally that LTi cells are required for the development of lymphoid 
tissues
12
. In the fetus, LTi cells are the only cells expressing RORt. In RORt-
deficient mice, LTi cells are absent and LNs and PPs fail to develop. These cells 
express several members of the TNF superfamily, such as soluble lymphotoxin (LT) 
3and its membrane-bound variant LT12, TRANCE and TRANCE-L
14, 31, 33
. 
LT12 is essential for the development of lymphoid tissues
34-36
, as it engages LTR 
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on specialized stroma cells, which in turninduces the expression of adhesion 
molecules and chemokines that recruit lymphocytes and myeloid cells
37
. 
 After birth, LTi cells cluster in hundreds of so-called cryptopatches 
(CPs)located between crypts of the intestinal lamina propria
38, 39
. CPs collect B cells 
todevelop into isolated lymphoid follicles (ILFs), which generate mostly T cell-
independent IgA
+
 B cells
40-42
. Surprisingly, the formation of ILFs from CPs requires 
bacterial microbiota
41, 43
. Proliferating bacteria release peptidoglycans from their cell 
wall, which is recognized by the innate receptor NOD-1 in epithelial cells
44
. This 
unleashes an activation cascade through the release of CCL-20, the activation of the 
CCR6
+
 (the receptor for CCL-20) LTi cells and stroma cells in CPs and the 
recruitment of B cells
43, 45
. In RORt-deficient mice, ILFs-like structures still 
develop
46
. However, these structures are termed tertiary lymphoid tissues (tLTs), 
which are induced by chronic inflammation in most organs independently of LTi 
cells, through the expression of LT12 by subsets of B cells, T cells or NK cells
47
.  
 Intriguingly, LTi cells are retained in mature (adult) LNs and Peyer’s patches, 
and locate in the cortex between B cell follicles
48
. Their functions in this region 
remains enigmatic, mainly because it has been so far impossible to investigate the 
consequence of a absence of LTi cells in adult lymphoid tissues, as RORt-deficient 
mice lack both.  
 
ILC3s 
A population of intestinal lymphoid cells expressing the NK marker NKp46 in mouse 
and NKp44 in human, were found to co-express RORt and IL-2219-22. These cells 
were originally named NK22 cells, but their requirement for RORt rather than 
Eomesin development, as well as their cytokine profile, makes them more similar to 
LTi cells than to NK cells. However, in contrast to LTi cells, NK22 do not cluster in 
CPs, and therefore, are not involved in the development of lymph nodes, Peyer’s 
patches and ILFs
49, 50
. Rather, NK22 are viewed as more “regular” effector cells that 
patrol the tissue and produce effector cytokines where it matters in terms of defense 
and injury
51
.  
 Given their common dependence on RORt and their similar cytokine profiles, 
LTi cells and NK22 cells were grouped together as ILC3s, while lymphoid cells that 
produce the type 2 cytokines IL-4, IL-5 and IL-13 were grouped as ILC2s, and those 
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that produce IFN as ILC1s23, 24.A difficulty arose when it was found that ILC3s can 
downregulate RORt and upregulate Tbet to produce IFNin a context of intense 
inflammation
52
. These cells were termed ex-ILC3s.Another form of ILC3 plasticity 
was found in vitrousing human ILC lines. When stimulated through TLR2, such lines 
expressed IL-5 and IL-13 in addition to IL-22
53
. It remains to be assessed to what 
extent such plasticity is operational in vivo, underlying for example the rapid response 
of ILCs to diverse types of tissue perturbations. 
 The prompt responsiveness of ILCsto infection and injuryplaces them 
upstream in the immune response. ILC3s are activated by the inducer cytokines IL-1 
and IL-23 produced by macrophages and DCs, typically in response to infection by 
extracellular bacteria and fungi. Activated ILC3s produce the effectors cytokines IL-
17, IL-22, GM-CSF, LT3and LT12, which in turn induce the production of anti-
microbial peptides (AMPs) by epithelial cells, of neutrophil-recruiting chemokines by 
stromal cells and epithelial cells
25, 54
, and the activation of B cells 
55, 56
. This antigen-
independent mode of activation of ILCs is similar to that of memory and “innate” T 
cells, at least in terms of kinetics
57
. It does not require selection and expansion of 
antigen-specific clones, but rather relies on the expansion of populations. It remains to 
be understood whether sub-subsets of ILCs exist and specifically expand in reaction 
to particular infections and injuries, thereby providing a form of immunological 
memory to challenges, as described for NK cells
58
. 
 ILC3s play a critical role early in the protection to enteropathogens, such as 
the proteobacteria Citrobacter rodentium, a homologue of the human E. coliintestinal 
pathogens
19
, to Salmonella enterica
52
and to rotaviruses
59
, through their production of 
IL-22. They also mediate containment of bacterial symbionts that live within Peyer’s 
patches
60
, and more generally protect from dextran sodium sulfate (DSS)-induced 
inflammation through the containment of symbiotic bacteria
46, 61
. The secretion by 
ILC3s of IL-22 also plays a role in the protection of epithelial cells from 
apoptosisinduced by chemotherapy or irradiationin the intestine and the thymus
62-64
, 
as well as in the protection of hepatocytes from inflammation
65
. Intriguingly, ILC3s 
are relatively resistant to irradiation and chemotherapy, possibly as a consequence of 
their low turnover
12, 49, 66
. 
 On the other hand, ILC3s and IL-22 are involved in the progression of colon 
cancer
67
, presumablybecause they protect epithelial cells from apoptosis through the 
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activation of the transcription factor STAT-3
62-64
. In addition, ILC3s contribute to 
inflammatory pathology through their capacity to co-expressIFNduring Salmonella 
infection in mouse
52
 and in animals and patients suffering from inflammatory bowel 
disease (IBD)
68, 69
. The expression of IL-17 by ILC3s is involved in obesity-
associated asthma induced by high fat diet
70
, possibly as a consequence of a loss of 
containment of the intestinal microbiota and an induction of ILC3s in adipose tissue 
by incoming bacteria and bacterial compounds
71
. 
 Another surprising feature of ILC3s is their expression of MHC class II
12, 14
, 
as well as of several components of the class II antigen-processing pathway. This 
feature allows the ILC3s to present antigens and repress the activity of specific T cells 
in the intestine during homeostasis
72
, and to induce T cells activation in the spleen
73
. 
The relative role of ILC3s, DCs and macrophages in the MHC class II-restricted 
activation and regulation of T cells
74
, at least in the intestine and the lymphoid tissues, 
remains to be measured.  
 So, ILC3s are pivotal to many processes in mucosal immunity, from the 
development of lymphoid tissues and the containment of the microbiota, the early 
immunity to pathogens and the protection of epithelial cells, to the exacerbation of 
inflammatory pathology and the progression of cancer. Even though ILC3s depend on 
RORt for their development, it remains to be determined whether RORt is also 
required for their maintenance, an important consideration when targeting RORt 
with agonists or antagonists to regulate type 3 immune responses
75, 76
. A recent report 
shows that a RORt antagonist leads to the loss of Th17 cells but not of ILC3s77.  
 
Thymocytes and Th17 cells 
RORt is required for the survival of immature CD4+CD8+ thymocytes by regulating 
the level of the anti-apoptotic factor Bcl-xL
10
. In the absence of RORt, immature 
thymocytes can spend less time at the CD4
+
CD8
+
 stage and therefore, recombination 
of the genes coding for the TCR chain is biased towards proximal V to J re-
arrangements
78
. The thymus of a RORt-deficient mouse contains half the number of 
cells found in the thymus of a wild-type animal
10
. In the periphery, control of anti-
apoptotic genesby RORt has not been reported. 
 Expression of RORt by T cells remained confined to immature thymocytes, 
until Th17 cells develop that require RORt18. Naive CD4+ T cells are induced into 
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the Th17 pathway by IL-179, IL-2317, 80, or the combination of IL-6 and TGF81-83. 
IL-23 and IL-6 induce the phosphorylation of STAT-3, which in turn induces the 
expression of RORt84. The characterization of Th17 cells was initially reported in the 
context of EAE as the cells that are induced by IL-23 to express IL-17 and provoke 
autoimmunity
17
, as well as in arthritis
85, 86
 and IBD
87, 88
. Therefore, RORtwas 
firstperceived as a public enemy that must be targeted to block the progression of 
autoimmune inflammation. Another line of research nevertheless showed the 
importance of Th17 cells in mucosal immunity to pathogens and their role in the 
containment of the microbiota through both the production of IL-17 and IL-22
89, 90
. 
 Caught in the middle of these confusing perceptions, IL-17 and IL-22 have 
been sometimes described as both pro- and anti-inflammatory, which only reflects the 
homeostatic or pathologic context in which these cytokines were studied. In contrast, 
ILC3s, also acting both during intestinal homeostasis and pathology, were first 
characterized in the context of intestinal homeostasis and thus as primarily 
“beneficial” cells39, 43. Nevertheless, the distinctive role of Th17 cells and ILC3s in 
homeostasis, defense and pathology has been difficult to pull apart, as models to 
ablate Th17 cells or ILC3s, individually, have to be improved 
19, 60
. Based on their 
innate versus adaptive nature, early responses against pathogens have generally been 
“assigned”to ILC3s, while chronic responses, such as autoimmune inflammation, 
have been assignedto Th17 cells. 
 The mechanisms by which microbes induce Th17 cells, and more generally 
type 3 immune responses,remain a hard nut to crack. Whereas it is clear that IL-1 
and IL-23 play a central role in the cascade of events that lead to the generation of 
Th17 cells
17, 79, 80, 91
, the signals that induce IL-23 are not known. It has been shown 
that ATP, produced by bacteria, activates a subset of intestinal lamina propria DCs 
through the P2X and P2Y receptors to produce IL-23
92
, but this mechanism remains 
to be validated in the context ofbacteria that adhere to epithelial cells, such as 
segmented filamentous bacteria (SFB)
93, 94
 and pathogenic strains of E. coli, which 
efficiently induce the generation of Th17 cells
95
. The pathway by which these 
adherent bacteria induce Th17 cells remains unknown. 
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Type 3 Tregs 
FoxP3 is the signature transcription factor for regulatory T (Treg) cells. Therefore, it 
came as a surprise that a significant proportion of intestinal FoxP3
+
 T cells also 
express RORt96. It was suggested that RORt+ FoxP3+ cells are not Tregs, but rather 
precursor T cells that express both transcription factors until expression of one is 
promoted over the other to generate Tregs or Th17 cells
83
. This hypothesis was 
derived form the observation that 25% of intestinal Th17 cells had expressed FoxP3 at 
some stage of their development, as determined by genetic fate mapping of FoxP3
+
 
cells. It was also suggested that Tregs acquire characteristics of effectors cells, 
induced by the inflammatory state of the tissue
97
. For example, colitis induces the 
expression of IL-23 by macrophages and DCs, which in turn induces the expression 
of RORt in developing effector T cells as well as in Tregs. This leads to the 
expression of the chemokine receptor CCR6 on both mature Th17 and RORt+ 
Tregs
96
, and thus co-localization of both the effector and the regulator cells to 
augment the efficacy of immune regulation
98
. Furthermore, a small proportion of 
RORt+ Tregs was found to be “perverted”into genuine effector cells, induced by 
chronic inflammationinto the expression of IL-17 
99
. 
 Nevertheless, the majority of RORt+ Tregs produces IL-10 at levels that 
exceed the levels produced by other subsets of Tregs, and express high levels of other 
attributes of Tregs, such as ICOS, CTLA-4, CD39 and CD73
100
, and exert regulatory 
functions in vitro and in vivo
96, 98
. Moreover, IL-10-producing RORt+ Tregs 
dramatically expand during intestinal and lung inflammation, presumably to avoid 
exponential growth of the inflammation
96
. Nevertheless, it is possible that the 
phenomenon of Treg “perversion” expandsduring chronic long-term inflammation, 
conditions found in the intestine of IBD and colon cancer patients
99
- but rarely 
obtained in mouse models.  
 Recently, it was demonstrated that microbiota- and antigen-induced Tregs 
express RORt, whereas microbiota-independent Tregs include asubset expressing 
Gata3
100-103
. The generation of RORt+ Tregs is dependent on antigen presentation by 
DCs and macrophages, as well as on the activation of STAT3
100
. Surprisingly, the 
“pro-Th17” cytokines IL-6 and IL-23, rather than IL-10, activate STAT3 for the 
generation of RORt+ Tregs. The eventual lineage choice to generate RORt+ Tregs 
instead of Th17 cells is dependent on the metabolism of vitamin A into retinoic acid 
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(RA), as an absence of vitamin A, or the inhibition of the RA receptor, tips the 
balance in favor of Th17 cells
100
. This suggests that the normal metabolism of vitamin 
A by DCs, stromal cells and neurons, rather than microbes, determines the balance 
between RORt+ Tregs and Th17, or in other words, between anti- and pro-
inflammatory (type 3) responses. I therefore propose that RA is a “normo-signal”, 
required in many physiological processes, which is used by the immune system to 
monitor the health state of a tissue. In the context of tissue damage,upon infection or 
injury, the production of RA is decreased and the balance between RORt+ Tregs and 
Th17 cells is shifted in favor of Th17 cells. During homeostasis in the intestine, this 
balance is regulated to the level of type 3 immunity required to contain the symbiotic 
microbiota. 
 In one study, the absence of RORt+ Tregs lead to the increase in Th1 and 
Th17 cells, and the exacerbation of colitis
101
. However, in another study, RORt+ 
Tregs were not found to control Th1 and Th17 cells, but rather Th2 cells
100
. It was 
proposed that bacteria induce type 3 responses, mediated by Th17 cells and RORt+ 
Tregs, which collectively repress competing type 1 or type 2 responses, a 
phenomenon described by the equilibrium model of immunity
104
. As a consequence, 
in mice that lack RORt+ Tregs or Th17 cells, anti-helminth responses are 
increasedand allergic inflammation is exacerbated.Thus microbiota regulates allergy 
through the induction of type 3 responses
100
. The exacerbated Th17 responses 
observed in the absence of RORt+ Tregs, reported in the first study101, may be the 
consequence of an intestinal microbiota that is more potently inducing type 3 
responses than in the second study 
100
.  
 The developmental origin of RORt+ Tregs remains debated and is difficult to 
address. Do they derive from Th17 cells, RORt- FoxP3+ Tregs, or naïve T cells? 
Genetic fate mapping, using Foxp3 or Rorc(t), cannot be conclusive, as FoxP3 is 
continuously expressed in the Treg lineage, whereas RORt is already expressed by 
immature CD4
+
CD8
+
 T cells in the thymus
39
. Resolution of the differentiation 
pathway of RORt+ Tregs requires the transfer of single T cells, or individual T cell 
barcoding. 
 
Other cells expressing RORt 
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RORt is expressed exclusively by lymphoid cells. Or so we thought. Populations of 
bone marrow and human blood neutrophils express RORt, as well as IL-17 upon 
stimulation with IL-6 and IL-23
105
. A similar subset of RORt+ neutrophils was 
identified in mice that expresses IL-17 upon Aspergillus fumigatus infection of the 
lungs
106
. These observations are reminiscent of older data showing that LPS induces 
lung neutrophilia, the recruitment of which is induced by CXC chemokines produced 
by stromal and epithelial cells. These chemokines are in turn induced by IL-17 
produced by neutrophils and T cells
107
.  
 
RORt as a molecule 
The natural ligand for RORt has remained elusive for long (Figure 2). The related 
ROR was co-crystallized with cholesterol and cholesterol sulfate108. Recently, it was 
found that cholesterol biosynthetic intermediates, such as oxysterols, are involved in 
the function of RORt during the development of lymph nodes and the differentiation 
of Th17 cells and IL-17
+
 Tcells 29, 109. These sterols are likely to be endogenous 
metabolites, rather than compounds derived from the microbiota, as lymph nodes and 
ILC3s develop in germ free animals. Interestingly, 7,27-hydroxycholesterol, is both 
a ligand for RORt and EBI2, a G protein-coupled receptor involved in the 
positioning of activated B cells in lymph nodes. The functional link between RORt 
and EBI2 remains unexplored
30
. 
 Synthetic inverse agonists of RORt have been identified that derive from 
LXR agonists 
75
or sterols such as digoxin 
76
 and ursolic acid 
110, 111
. Such compounds 
trigger intense interests from the pharmaceutic industry as drugs to block type 3 
responses during autoimmunity and IBD. Evidently, given the multiple cells and 
pathways that depend on RORt, including the containment of the intestinal 
microbiota and the regulation of competing immune responses such as allergic 
responses, such a strategy may cause important collateral damage, or be inefficient in 
the intestine
46, 100
. It is possible that for similar reasons, anti-IL-23 treatment is 
inefficient or even deleterious in the context of IBD, even though it is very efficient in 
the context of skin disease
112
. Interestingly, it appears that Th17 cells are more 
sensitive to transient RORt inhibition than ILC3s77, indicating that partial blockage 
of type 3 responses can be achieved with RORt inhibitors that may preserve the 
activity of ILC3s and some level of microbial containment.  
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 Regulation of RORt also occurs at the protein-protein level. Itch is an E3 
ubiquitin ligase that binds RORt and targets it for ubiquitination and degradation113. 
In the absence of Itch, mice develop IL-17-dependent intestinal inflammation and 
tumorigenesis. Nitric oxide (NO) also regulates the activity of RORt through 
nitration of tyrosine residues
114
. As a consequence, iNOS-deficient mice develop 
enhanced Th17 differentiation. At the transcription factor level, FoxP3 binds directly 
to RORtand appears to impose its anti-inflammatory programin RORt+ Tregs over 
the pro-inflammatory program induced by RORt83, 96. Gata3, the signature 
transcription factor of type 2 responses, directly binds to and inhibits the Rorc 
promoter
103
. Finally, T-bet, the signature transcription factor of type 1 responses, 
prevents Runx1 to mediate transactivation of Rorc
115
.  
 An interesting twist in the regulation of RORt expression involves Nfil3. This 
basic leucine zipper transcription factor is required for the development of NK 
cells
116
, as well as more generally for the development of ILCs
117-119
. Nfil3 is 
negatively regulated by the clock protein Rev-Erb, and in turn, negatively regulates 
expression of RORt by directly binding to the Rorc promoter28. As a consequence, 
the expression of RORt, and the amplitude of type 3 responses, is regulated by the 
circadian clock, and disruption of the circadian rhythm leads to increased 
susceptibility to type 3 inflammatory pathology.  
 
RORt and ROR 
ROR directly regulates the expression of clock genes through binding to the 
promoter of Cry1, Bmal1, Rev-Erb and also Nfil3120. Thus, ROR regulates clock 
genes, and one of those clock genes, Nfil3, regulates RORt28. However, ROR and 
RORt are not usually co-expressed in the same type of cells. Whereas RORt is 
expressed in lymphoid cells (and neutrophils) exclusively, ROR is not expressed in 
hematopoietic cells, but in many other types of parenchymal cells, such as 
hepatocytes and muscle cells
9
. Therefore, it is possible that ROR and RORt have 
similarbiology in different cells, both connected to circadian clocks and oxysterol 
ligands
29, 109
, but have different functions through the regulation of distinct set of 
tissue-specific genes. 
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 Interestingly, the other members of the ROR family, ROR and ROR, also 
play important roles in the circadian rhythms, as both ROR-deficient mice and 
ROR-deficient mice show alterations in circadian oscillations121. 
 
Concluding remarks 
RORt has turned out to be an extraordinary nuclear receptor and transcription factor, 
which controls type 3 immunity, a critical branch of immune responses that contains 
the symbiotic microbiota at mucosal surfaces and fights bacterial and fungal 
pathogens, but also leads to autoimmunity and cancer. The links between RORt, 
oxysterols and clock genes makes RORt a potential node connecting immunity with 
metabolism and circadian rhythms. The biology of RORt blossoms at an exciting 
time as immunology expands into a more transversal field of research connecting 
different physiological systems. 
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Figure legends 
 
Figure 1. The RORt+ cells. 
RORt+ cells include type 3 innate lymphoid cells (ILC3s) and several subsets of T 
cells (Th17 cells, invariant NKT cells, T cells). Not mentioned is a subset of IL-17-
producing neutrophils that has been documented in mouse and man (see text). All 
RORt+ cells can express the effector cytokines IL-17 and IL-22 to varying degrees, 
except most RORt+ regulatory T cells (microbiota-induced or iTregs) that express 
IL-10. A subset of ILC3s, named lymphoid tissue inducer (LTi) cells, expresses 
soluble (LT3) and membrane-bound (LT12) lymphotoxin, as well as TRANCE 
and TRANCE ligand, which are involved in the development of lymphoid tissues in 
the fetus and after birth in the intestinal lamina propria and the activation of B cells. 
IL-17, as well as LT12, induces the recruitment of neutrophils, IL-22 prevents 
apoptosis of epithelial stem cells, and both IL-17 and IL-22 induce the production of 
anti-microbial peptides (AMPs) by epithelial cells. RORt+ Tregs are induced by the 
symbiotic microbiota and regulate competing type 1 and type 2 responses.  
 
Figure 2. The RORt molecule. 
The type 3 inducer cytokines IL-23 and IL-6 induce the phosphorylation of the 
transcription factor STAT3, which then activates Rorc(t), the gene coding for RORt 
that is essential for the generation of ILC3s and RORt+ T cells. RORt then induces 
the expression of the type 3 effector cytokines IL-17 and IL-22. FoxP3, the signature 
transcription factor of Treg cells, binds RORt and generally imposes a regulatory 
phenotype to FoxP3
+
 RORt+(Treg) cells. Similarly, Gata3 and T-bet, the signature 
transcription factor of type 2 and type 1 lymphoid cells, respectively, block the 
expression of RORt. The expression of RORt is also under control of the circadian 
rhythm, as Nfil3, regulated by clock genes, represses Rorc(t). ROR is involved in 
the regulation of circadian clocks, but is not normally expressed by hematopoietic 
cells. Natural ligands of RORt have recently been identified as oxysterols, the 
biology of which remains to be fully understood.  
  
  
 
